NCT04004910: Immunopheresis Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Advanced Triple Negative Breast Cancer (TNBC)

NCT04004910
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Ph+ase 1|Ph+ase 2
Drug Category: Chemotherapy, Other

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients with leptomeningeal disease or symptomatic CNS metastases that are neurologically unstable or require treatment- see trial for details
https://ClinicalTrials.gov/show/NCT04004910

Comments are closed.

Up ↑